Table 2.
Details of the patients.
Patient Number | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 |
---|---|---|---|---|---|---|---|---|---|
Sex | female | male | female | female | female | female | female | female | male |
Age at diagnosis (years) | 23 | 55 | 16 | 13 | 20 | 31 | 33 | 18 | 29 |
Family number | 1 | 2 | 2 | 3 | 3 | 4 | 5 | 6 | 7 |
Gene mutation (mutation sequence) | not screened | RYR2 (D2216G) | RYR2 (D2216G) | RYR2 (L2432F) | RYR2 (L2432F) |
RYR2 (M4002V) | 0 | 0 | 0 |
Initial medical treatment | Metoprolol 50 mg/day | no medical treatment | Bisoprolol 2.5 mg/day | Bisoprolol 2.5 mg/day | no medical treatment | Metoprolol 200 mg/day | Propafenone 450 mg/day | Metoprolol 150 mg/day | Propanolol (dosage not available) |
Changed medical treatment | refused | no medical treatment | Metoprolol 25 mg/day | Bisoprolol 5 mg/day | no medical treatment | Metoprolol 200 mg/day + Flecainide 200 mg/day | Metoprolol 100 mg/day | Metoprolol 150 mg/day | refused |
Current medical treatment | refused | no medical treatment | Metoprolol 100 mg/day | Bisoprolol 5 mg/day + Flecainide 200 mg/day | no medical treatment | Metoprolol 200 mg/day + Flecainide 200 mg/day | Metoprolol 100 mg/day + Flecainide 100 mg/day | refused | refused |